Elexacaftor\/tezacaftor\/ivacaftor, sold under the brand name Trikafta, is a fixed-dose combination medication used in those that have cystic fibrosis with a f508del mutation. It is made up of a combination of elexacaftor, tezacaftor, and ivacaftor.<\/strong>\u00a0It was approved for medical use in the United States in 2019. In June 2020, the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) recommended the approval of elexacaftor\/tezacaftor\/ivacaftor (Kaftrio) for the treatment of cystic fibrosis. It was approved for medical use in the European Union in August 2020.<\/p>\n If TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets)<\/strong> are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n Note:<\/strong> NEWS \/ UPDATES<\/strong><\/p>\n TRIKAFTA is a combination of ivacaftor, a CFTR potentiator, tezacaftor, and elexacaftor indicated for the treatment of cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the CFTR gene.<\/strong>\u00a0If the patient\u2019s genotype is unknown, an FDA-cleared CF mutation test should be used to confirm the presence of at least one F508del mutation.<\/p>\n Source content :\u00a0www.accessdata.fda.gov<\/a><\/p>\n If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets)\u201d <\/strong> based on the information you provide.<\/p>\nHow can 1 go about obtaining TRIKAFTA ?<\/h4>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/p>\n\n
TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets), co-packaged for oral use.<\/h1>\n
\n\n
\n Brand Name:<\/strong><\/td>\n TRIKAFTA<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n elexacaftor, tezacaftor and ivacaftor tablets<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u2022 Tablets: Fixed-dose combination containing elexacaftor 50 mg, tezacaftor 25 mg and ivacaftor 37.5 mg co-packaged with ivacaftor 75 mg.<\/td>\n<\/tr>\n \n Manufacturer:<\/strong><\/td>\n Vertex Pharmaceuticals<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Access the best support services globally<\/h4>\n